Schizophrenia: from developmental deviance to dopamine dysregulation.
about
Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophreniaMismatch negativity: translating the potentialMutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathologyGenetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia.Assessment between Dopamine Receptor D2 (DRD2) Polymorphisms and Schizophrenia in Korean Population.Animal models of schizophrenia.Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families.Transient knockdown of tyrosine hydroxylase during development has persistent effects on behaviour in adult zebrafish (Danio rerio).Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood.Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study.Migration, ethnicity, and psychosis: toward a sociodevelopmental modelSchizophrenia: an integrated sociodevelopmental-cognitive model.Adolescent self-control predicts midlife hallucinatory experiences: 40-year follow-up of a national birth cohortHypoxic induction of the regulator of G-protein signalling 4 gene is mediated by the hypoxia-inducible factor pathway.Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light.Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokineticsAttitudes towards cannabis use and genetic testing for schizophrenia.Different rates of first admissions for psychosis in migrant groups in Paris.Metabolome in schizophrenia and other psychotic disorders: a general population-based study.Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats.The epidemiology of schizophrenia: replacing dogma with knowledgeExtracellular matrix abnormalities in schizophreniaPrefrontal and striatal volumes in monozygotic twins concordant and discordant for schizophrenia.Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls.Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models.Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophreniaThe Impact of Maternal Vitamin D Status on Offspring Brain Development and Function: a Systematic ReviewEtiological and clinical features of childhood psychotic symptoms: results from a birth cohort.High precision liquid chromatography analysis of dopaminergic and serotoninergic responses to acute alcohol exposure in zebrafish.Young rural people at risk for schizophrenia: time for mental health services to translate research evidence into best practice of care.Leading compounds for the validation of animal models of psychopathology.Memory reconsolidation in aversive and appetitive settings.What can we learn about schizophrenia from studying the human model, drug-induced psychosis?Consequences at adulthood of transient inactivation of the parahippocampal and prefrontal regions during early development: new insights from a disconnection animal model for schizophreniaBDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory.Functional -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter and schizophrenia in a Chinese Han population.Linking substance use with symptoms of subclinical psychosis in a community cohort over 30 years.The amphetamine sensitization model of schizophrenia symptoms and its effect on schedule-induced polydipsia in the rat.Unemployment, ethnicity and psychosis.
P2860
Q24632939-28D01A3E-2AC8-40CD-8B19-B488B4312F65Q26830827-56D1C09D-7C1A-4F2E-96C5-8A10098FB587Q27315950-CB70F4AA-B028-4459-A510-22896D147761Q30442031-E7A3CBF7-5458-46FD-96AA-C806B1F563D4Q30458046-E2EB5A01-6AEE-4A25-826B-ED626CF01CF3Q30462828-6ED98A8D-956A-4734-B4D4-5900619F8440Q30474699-3E45570C-45C3-420A-9F7D-DBB6CFD8D58EQ31083717-39F63313-B464-47C1-9453-1386B359C0C3Q33651050-70345CFE-D320-4CC8-8EF3-2702023DC9AFQ33933939-B4109591-ED25-41BB-B417-50F9A9FD3022Q33950881-EBDFD72F-06D5-456E-8856-3FC32313AE81Q34023115-17AECD9B-AF88-4286-9E5E-19F103962EA3Q34323043-E4AD3DB2-04D8-495B-9EB6-3187B4D3CB6CQ34412532-03C0645E-B36D-4E74-9675-644B02319ACCQ34509725-4D12D334-0DEE-421D-B041-62DEA6D837BDQ34667775-627770EF-7304-4674-A145-2F531A095DF4Q34765918-EC0311E1-12D5-4959-A733-7554996ACCEBQ34811849-3D05C588-232D-4FB4-9CDE-EF84BC7E2454Q34971495-531ACA8B-52F1-4172-AFDB-450143BD8E3EQ35206798-6ABFDA03-7EEE-451E-9C07-0D96A3EC0586Q35237282-1960235F-6C7B-46E2-B878-D62BCFD43A5BQ35603175-5B4887AF-70CF-4032-9BC7-F866F6BBA8C9Q35632540-280BC864-39EA-4B67-BEFC-25C442DA9679Q35774591-8466631E-787D-48F9-86B8-5FFD85AEA6CBQ35844335-B5DEE57F-6120-42D2-96F7-C3CA29B7F4D4Q36246819-558F18B2-E756-40AF-B1AF-650B141CDB82Q37019129-0855F36C-5D4A-4BC5-A99D-CF2EA8B477A4Q37089776-02F45EF0-3E3E-4146-A337-BCED92FECF8DQ37180961-44E1181F-C9FB-44A3-8064-1BEFC9509A8EQ37259748-3C89C35D-5C39-48CF-B729-187FC2F78479Q37798832-A2638280-AB99-4B15-ACFA-20D051AC4193Q38128733-694795EE-1463-4F34-A14F-BE82D4F4E8AAQ38140857-35304F79-A117-4252-A030-C5668B6F1E7FQ38153344-D6823146-73E5-4B99-A291-1F356815C48CQ38207989-1032AE04-1162-47BB-8710-2C3B5F3C83BAQ42157677-4CA8F9F6-F628-4EE6-8E39-C2B852A3302DQ43848842-41BA8BD3-E889-49CE-81FB-18AB35F826D5Q44053144-85C3587C-CC4E-474E-A673-58177BC690A3Q44600763-B64A6D20-5120-416B-87C4-CE2BBD25C0BCQ46976976-527D5F92-F883-461C-8925-DADAFA421253
P2860
Schizophrenia: from developmental deviance to dopamine dysregulation.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Schizophrenia: from developmental deviance to dopamine dysregulation.
@ast
Schizophrenia: from developmental deviance to dopamine dysregulation.
@en
Schizophrenia: from developmental deviance to dopamine dysregulation.
@nl
type
label
Schizophrenia: from developmental deviance to dopamine dysregulation.
@ast
Schizophrenia: from developmental deviance to dopamine dysregulation.
@en
Schizophrenia: from developmental deviance to dopamine dysregulation.
@nl
prefLabel
Schizophrenia: from developmental deviance to dopamine dysregulation.
@ast
Schizophrenia: from developmental deviance to dopamine dysregulation.
@en
Schizophrenia: from developmental deviance to dopamine dysregulation.
@nl
P1476
Schizophrenia: from developmental deviance to dopamine dysregulation.
@en
P2093
Marta Di Forti
P304
P356
10.1016/J.EURONEURO.2008.04.002
P407
P478
18 Suppl 3
P577
2008-05-21T00:00:00Z